✦ LIBER ✦

Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial

✍ Scribed by N Guañabens; J Farrerons; L Perez-Edo; A Monegal; A Renau; J Carbonell; M Roca; M Torra; M Pavesi

Book ID: 117806981
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 115 KB
Volume: 27
Category: Article
ISSN: 8756-3282
DOI: 10.1016/s8756-3282(00)00303-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the efficiency and safety

Comparison of the efficiency and safety of cyclic etidronate versus sodium fluoride in postmenopausal osteoporosis

✍ N. Guañabens; J. Farrerons; L. Perez-Edo; A. Monegal; A. Renau; M. Roca; M. Pave 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 152 KB

Cyclical etidronate versus sodium fluori

Cyclical etidronate versus sodium fluoride for treatment of osteoporosis in primary biliary cirrhosis. Preliminary results after two years

✍ N. Guanabens; A. Pares; A. Mopegal; P. Peris; F. Pons; L. Alvarez; M. J. Martine 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 130 KB

A Comparison of Continuous Alendronate,

A Comparison of Continuous Alendronate, Cyclical Alendronate and Cyclical Etidronate with Calcitriol in the Treatment of Postmenopausal Vertebral Osteoporosis: A Randomized Controlled Trial

✍ O. Sahota; I. Fowler; P. J. Blackwell; N. Lawson; S. A. Cawte; P. San; T. Masud; 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 164 KB

Comparison of nonrandomized trials with

Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis

✍ Dr. Charles Y.C. Pak; Khashayar Sakhaee; Norman H. Bell; Angelo Licata; Conrad J 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 786 KB

The results of slow-release sodium fluoride (SR-NaF) treatment in two nonrandomized trials involving 65 patients with postmenopausal osteoporosis from the primary site and 121 patients from collaborative sites were compared with those obtained from 54 treated patients and 56 patients taking placebo

Safety and tolerability of bazedoxifene

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

✍ T. J. de Villiers; A. A. Chines; S. Palacios; P. Lips; A. Z. Sawicki; A. B. Levi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 269 KB

Safety and tolerability of bazedoxifene

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results of A 5-year, randomized, placebo-controlled phase 3 trial

✍ T.J. de Villiers; D.L. Kendler; A.A. Chines; P. Lips; J.M. Kaufman; A.B. Levine; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB